Stanford ChEM-H and Genentech have partnered to create opportunities for Genentech scientists and Stanford faculty to jointly mentor postdoctoral scholars. Prospective postdoctoral fellows should search for opportunities directly through Genentech's employment portal.
Nathaniel Stanley, Ph.D.
Vijay Pande, Ph.D., Camille and Henry Dreyfus Distinguished Chair in Chemistry, Professor of Structural Biology and of Computer Science
Ben Sellers, Ph.D., Computational Chemist, Discovery Chemistry / Computational Drug Discovery
Nathaniel Stanley received his bachelor’s degree in Biochemistry from New York University in 2006. He then spent several years working at a thin-film solar energy start-up company in the San Francisco Bay area. Determined that the power of biology would help solve numerous fundamental human problems, he returned to school to get his PhD in Biomedicine from the group of Gianni De Fabritiis at the Universitat Pompeu Fabra. There he studied the use of massively parallel molecular simulations to better understand disordered and membrane proteins. In his joint position between Genentech and Stanford, he is now focused on furthering the use of such methods for biological discovery and drug design.
David Hewings, Ph.D.
Matthew Bogyo, Ph.D., Professor of Pathology and of Microbiology and Imunnology and, by courtesy, of Chemical and Systems Biology
John Flygare, Ph.D., Principal Scientist, and Ingrid Wertz M.D. Ph.D, Scientist, Molecular Oncology
David Hewings completed his undergraduate degree in Chemistry at the University of Oxford, where he stayed to study for both a Masters in Medicinal Chemistry for Cancer and a doctoral degree in Organic Chemistry. During his graduate studies he developed inhibitors of the protein-protein interaction between acetylated histones and their binding partners, bromodomians, under the supervision of Prof. Stuart Conway. He moved to California in 2014 to work with Prof. Eric Kool and Dr. Ash Alizadeh at Stanford on RNA detection and isolation techniques. In his current position, he is applying activity-baed probes to study protease function in cancer, with a particular focus on deubiquitinating enzymes.